KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 26 | -94.9% | 0.00% | – |
| Q2 2023 | $2,000 | -84.6% | 505 | -76.4% | 0.00% | – |
| Q1 2023 | $13,000 | -59.4% | 2,139 | -59.5% | 0.00% | – |
| Q4 2022 | $32,000 | +220.0% | 5,275 | +516.2% | 0.00% | – |
| Q3 2022 | $10,000 | +25.0% | 856 | +28.9% | 0.00% | – |
| Q2 2022 | $8,000 | -66.7% | 664 | -68.1% | 0.00% | – |
| Q1 2022 | $24,000 | -76.0% | 2,082 | -62.7% | 0.00% | – |
| Q4 2021 | $100,000 | +17.6% | 5,586 | +52.5% | 0.00% | – |
| Q3 2021 | $85,000 | +77.1% | 3,663 | +82.1% | 0.00% | – |
| Q2 2021 | $48,000 | -14.3% | 2,012 | +12.5% | 0.00% | – |
| Q1 2021 | $56,000 | +180.0% | 1,788 | +257.6% | 0.00% | – |
| Q4 2020 | $20,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |